Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

5589 ARTÍCULOS , VIENDO DEL 4951 AL 4965

The role of Shh signalling pathway in central nervous system development and related diseases

Li X, Li Y, Li S, Li H, Yang C, Lin J.

Cell Biochem Funct. 2021 Mar;39(2):180-189. doi: 10.1002/cbf.3582. Epub 2020 Aug 25.

Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Oral Venglustat in Healthy Volunteers

Peterschmitt MJ, Crawford NPS, Gaemers SJM, Ji AJ, Sharma J, Pham TT.

Clin Pharmacol Drug Dev. 2021 Jan;10(1):86-98. doi: 10.1002/cpdd.865. Epub 2020 Aug 26.

COVID-19: dealing with a potential risk factor for chronic neurological disorders

Schirinzi T, Landi D, Liguori C.

J Neurol. 2021 Apr;268(4):1171-1178. doi: 10.1007/s00415-020-10131-y. Epub 2020 Aug 27.

Deep brain stimulation in Parkinson's disease patients and routine 6-OHDA rodent models: Synergies and pitfalls

Stefani A, Cerroni R, Pierantozzi M, D'Angelo V, Grandi L, Spanetta M, Galati S.

Eur J Neurosci. 2021 Apr;53(7):2322-2343. doi: 10.1111/ejn.14950. Epub 2020 Oct 23.

Interventions Involving Biofeedback to Improve Swallowing in People With Parkinson Disease and Dysphagia: A Systematic Review

Battel I, Calvo I, Walshe M.

Arch Phys Med Rehabil. 2021 Feb;102(2):314-322. doi: 10.1016/j.apmr.2020.06.033. Epub 2020 Aug 27.

Early-start vs delayed-start donepezil against cognitive decline in Parkinson disease: a randomized clinical trial

Sawada H, Oeda T, Kohsaka M, Tomita S, Umemura A, Park K, Yamamoto K, Kiyohara K.

Expert Opin Pharmacother. 2021 Feb;22(3):363-371. doi: 10.1080/14656566.2020.1814255. Epub 2020 Aug 31.

Altered awareness of cognitive and neuropsychiatric symptoms in Parkinson's disease and Dementia with Lewy Bodies: A systematic review

Pennington C, Duncan G, Ritchie C.

Int J Geriatr Psychiatry. 2021 Jan;36(1):15-30. doi: 10.1002/gps.5415. Epub 2020 Sep 14.

Analysis of DNM3 and VAMP4 as genetic modifiers of LRRK2 Parkinson's disease

Brown EE, Blauwendraat C, Trinh J, Rizig M, Nalls MA, Leveille E, Ruskey JA, Jonvik H, Tan MMX, Bandres-Ciga S, Hassin-Baer S, Brockmann K, Infante J, Tolosa E, Ezquerra M, Ben Romdhan S, Benmahdjoub M, Arezki M, Mhiri C, Hardy J, Singleton AB, Alcalay RN, Gasser T, Grosset DG, Williams NM, Pittman A, Gan-Or Z, Fernandez-Santiago R, Brice A, Lesage S, Farrer M, Wood N, Morris HR; International Parkinson Disease Genomics Consortium (IPDGC).

Neurobiol Aging. 2021 Jan;97:148.e17-148.e24. doi: 10.1016/j.neurobiolaging.2020.07.002. Epub 2020 Jul 13.

Prevalence and impact of COVID-19 in Parkinson's disease: evidence from a multi-center survey in Tuscany region

Del Prete E, Francesconi A, Palermo G, Mazzucchi S, Frosini D, Morganti R, Coleschi P, Raglione LM, Vanni P, Ramat S, Novelli A, Napolitano A, Battisti C, Giuntini M, Rossi C, Menichetti C, Ulivelli M, De Franco V, Rossi S, Bonuccelli U, Ceravolo R; Tuscany Parkinson COVID-19 Participants.

J Neurol. 2021 Apr;268(4):1179-1187. doi: 10.1007/s00415-020-10002-6. Epub 2020 Sep 3.

Metabolic determinants of leukocyte pathogenicity in neurological diseases

Runtsch MC, Ferrara G, Angiari S.

J Neurochem. 2021 Jul;158(1):36-58. doi: 10.1111/jnc.15169. Epub 2020 Sep 22.

Diagnostic performance of neuromelanin-sensitive magnetic resonance imaging for patients with Parkinson's disease and factor analysis for its heterogeneity: a systematic review and meta-analysis

Cho SJ, Bae YJ, Kim JM, Kim D, Baik SH, Sunwoo L, Choi BS, Kim JH.

Eur Radiol. 2021 Mar;31(3):1268-1280. doi: 10.1007/s00330-020-07240-7. Epub 2020 Sep 4.

Effect of ketogenic diet versus regular diet on voice quality of patients with Parkinson's disease

Koyuncu H, Fidan V, Toktas H, Binay O, Celik H.

Acta Neurol Belg. 2021 Dec;121(6):1729-1732. doi: 10.1007/s13760-020-01486-0. Epub 2020 Sep 6.

A double-blind randomized controlled trial of the efficacy of cognitive training delivered using two different methods in mild cognitive impairment in Parkinson's disease: preliminary report of benefits associated with the use of a computerized tool

Bernini S, Panzarasa S, Barbieri M, Sinforiani E, Quaglini S, Tassorelli C, Bottiroli S.

Aging Clin Exp Res. 2021 Jun;33(6):1567-1575. doi: 10.1007/s40520-020-01665-2. Epub 2020 Sep 8.

Challenges and Opportunities of Deferoxamine Delivery for Treatment of Alzheimer's Disease, Parkinson's Disease, and Intracerebral Hemorrhage

Farr AC, Xiong MP.

Mol Pharm. 2021 Feb 1;18(2):593-609. doi: 10.1021/acs.molpharmaceut.0c00474. Epub 2020 Oct 9.

Vicia plants-A comprehensive review on chemical composition and phytopharmacology

Salehi B, Abu-Reidah IM, Sharopov F, Karazhan N, Sharifi-Rad J, Akram M, Daniyal M, Khan FS, Abbaass W, Zainab R, Carbone K, Fahmy NM, Al-Sayed E, El-Shazly M, Lucarini M, Durazzo A, Santini A, Martorell M, Pezzani R.

Phytother Res. 2021 Feb;35(2):790-809. doi: 10.1002/ptr.6863. Epub 2020 Sep 15.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias